![Calvin Yu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Calvin Yu worked as Senior Director-Finance & SEC Reporting at Adverum Biotechnologies, Inc. from 2014 to 2016.
Prior to that, he worked as Controller at Five Prime Therapeutics, Inc. from 2010 to 2014.
He also worked as Controller at Stemcentrx, Inc. from 2016 to 2017.
Currently, he is the Chief Financial & Accounting Officer at Alector, Inc. Mr. Yu completed his undergraduate degree from San Francisco State University.
Eerdere bekende functies van Calvin Yu
| Bedrijven | Functie | Einde |
|---|---|---|
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Comptroller/Controller/Auditor | 01-06-2017 |
| ADVERUM BIOTECHNOLOGIES, INC. | Financieel Directeur/CFO | 01-02-2016 |
| FIVE PRIME THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-09-2014 |
| ALECTOR, INC. | Financieel Directeur/CFO | 08-09-2021 |
Opleiding van Calvin Yu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
17
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Health Technology |
San Francisco State University
 San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
